Welcome to Media Relations for the University of Maryland Medical Center. Our media team works with journalists every day to bring timely and important health stories of innovation, research, and breaking news.
To reach a member of the Media Team:
- Email email@example.com (monitored every day, 24/7)
- Call 410-328-8919 during regular business hours
University of Maryland Children’s Heart Program Ranked by US News & World Report for 3rd Consecutive YearJune 16, 2020
Fentanyl Tops List of Drugs Found in Baltimore Overdose PatientsJune 11, 2020
A new University of Maryland study found fentanyl tops the list of drugs detected in overdose patients at two Baltimore hospital emergency departments. The study is based on de-identified urinalysis results and other data collected through the new Maryland Emergency Department Drug Surveillance (EDDS) system, from January 2016 through December 2019. Fentanyl testing was incorporated for all patients undergoing urine screens as a routine test at these hospitals in January 2019.
UM School of Medicine Begins First Innovative Trial of Experimental Stem Cell Therapy to Reduce Deaths in Sickest COVID-19 PatientsMay 21, 2020
Researchers at the University of Maryland School of Medicine (UMSOM) have begun testing an experimental stem cell therapy developed by Mesoblast Limited to treat hospitalized COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS) who are on ventilators to help them breathe.
University of Maryland Medical System Announces Visitor Policy Changes At All Facilities In Response To COVID-19March 10, 2020
Addition of MRI-Targeted Biopsy Leads to more Reliable Diagnosis of Aggressive Prostate CancerMarch 03, 2020
University of Maryland Greenebaum Comprehensive Cancer Center Joins the Big Ten Cancer Research ConsortiumJanuary 21, 2020
University of Maryland Medical Center is Baby FriendlyDecember 05, 2019
The University of Maryland Medical Center (UMMC) is proud to announce that it has achieved the highly prestigious international Baby-Friendly designation after a rigorous review process conducted by Baby-Friendly USA, the organization responsible for bestowing this certification in the United States.
University of Maryland Medicine Launches Treatment Centers for Adult Neurodevelopmental DisabilitiesDecember 05, 2019
The University of Maryland School of Medicine (UMSOM), University of Maryland Medical Center (UMMC), and the Tuberous Sclerosis Alliance (TS Alliance) have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.
Inhaled Immunosuppressant May Increase Survival, Boost Pulmonary Function after Lung TransplantNovember 13, 2019
University of Maryland School of Medicine (UMSOM) researchers found that lung transplant recipients who had early signs of organ rejection could increase their chances of survival by using an inhaled form of the immunosuppressive drug cyclosporine.